Vimarsana
Biggest News Aggregation in the World

Smith Laboratories News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Smith Laboratories. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Smith Laboratories Today - Breaking & Trending Today

UPSHER-SMITH PREVIEWS EXPANSION OF ITS RARE DISEASE PORTFOLIO AT 2024 AAN ANNUAL MEETING - Vimarsana News

UPSHER-SMITH PREVIEWS EXPANSION OF ITS RARE DISEASE PORTFOLIO AT 2024 AAN ANNUAL MEETING

/PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be participating in the 2024 American Academy of Neurology (AAN)...

Bora Pharmaceuticals Acquires Upsher-Smith from Sawai and Sumitomo - Vimarsana News

Bora Pharmaceuticals Acquires Upsher-Smith from Sawai and Sumitomo

Bora Pharmaceuticals Co., Ltd. yesterday (April 1) finalized the acquisition of Upsher-Smith Laboratories, Inc., a leading generics manufacturer based in Minnesota, U.S., from its previous owners, Sawai Group Holdings and Sumitomo Corporation of Americas.

© 2023 Tonix Pharmaceuticals Holding Corp. INVESTOR PRESENTATION NASDAQ: TNXP Version P04 88 September 25 , 2023 (Doc 1321 ) - Form 8-K -September 25, 2023 at 04:40 pm EDT - Vimarsana News

© 2023 Tonix Pharmaceuticals Holding Corp. INVESTOR PRESENTATION NASDAQ: TNXP Version P04 88 September 25 , 2023 (Doc 1321 ) - Form 8-K -September 25, 2023 at 04:40 pm EDT

T ianeptine - tianeptine 1 Stablon. Summary of product characteristics. Les Laboratoires Servier Industrie ; 2014. 2 PubChem. Accessed November 10, 2022....

Lupin : July 14, 2023 Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP - Vimarsana News

Lupin : July 14, 2023 Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP

Mumbai, Baltimore, July 14, 2023: Global pharma major Lupin Limited today announced that its wholly-owned subsidiary, Lupin Inc., based in Somerset, New Jersey, has received approval...

Tonix Pharmaceuticals Enters into Agreement to Acquire Two FDA-Approved, Marketed Migraine Products from Upsher-Smith Laboratories, LLC - Tonix Pharmaceuticals (NASDAQ:TNXP) - Vimarsana News

Tonix Pharmaceuticals Enters into Agreement to Acquire Two FDA-Approved, Marketed Migraine Products from Upsher-Smith Laboratories, LLC - Tonix Pharmaceuticals (NASDAQ:TNXP)

Zembrace® SymTouch® (sumatriptan injection) and Tosymra® (sumatriptan nasal spray) are Indicated for the Treatment of Acute Migraine in Adults Strategic Acquisition Helps Build Tonix's Commercial